GP-Act III Acquisition (NASDAQ:GPAT) Issues Quarterly Earnings Results

GP-Act III Acquisition (NASDAQ:GPATGet Free Report) issued its quarterly earnings data on Thursday. The company reported $0.08 EPS for the quarter, FiscalAI reports.

GP-Act III Acquisition Stock Performance

Shares of GPAT stock traded up $0.03 during mid-day trading on Thursday, reaching $10.83. 513,912 shares of the stock traded hands, compared to its average volume of 52,103. The stock’s fifty day simple moving average is $10.76 and its two-hundred day simple moving average is $10.69. GP-Act III Acquisition has a 1-year low of $10.30 and a 1-year high of $10.83.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GP-Act III Acquisition presently has an average rating of “Sell”.

Check Out Our Latest Analysis on GP-Act III Acquisition

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in GPAT. Longfellow Investment Management Co. LLC acquired a new stake in GP-Act III Acquisition during the 3rd quarter worth approximately $83,000. Bank of America Corp DE bought a new position in shares of GP-Act III Acquisition during the third quarter valued at $85,000. Clear Street Group Inc. bought a new position in shares of GP-Act III Acquisition during the third quarter valued at $109,000. Clear Street LLC lifted its holdings in shares of GP-Act III Acquisition by 8,429.8% during the second quarter. Clear Street LLC now owns 10,321 shares of the company’s stock worth $109,000 after purchasing an additional 10,200 shares during the period. Finally, Cannon Global Investment Management LLC acquired a new position in shares of GP-Act III Acquisition during the third quarter worth $111,000.

GP-Act III Acquisition Company Profile

(Get Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Further Reading

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.